A Bayesian approach to estimating the population prevalence of mood and anxiety disorders using multiple measures.


Journal

Epidemiology and psychiatric sciences
ISSN: 2045-7979
Titre abrégé: Epidemiol Psychiatr Sci
Pays: England
ID NLM: 101561091

Informations de publication

Date de publication:
08 Jan 2021
Historique:
entrez: 8 1 2021
pubmed: 9 1 2021
medline: 16 1 2021
Statut: epublish

Résumé

There is currently no universally accepted measure for population-based surveillance of mood and anxiety disorders. As such, the use of multiple linked measures could provide a more accurate estimate of population prevalence. Our primary objective was to apply Bayesian methods to two commonly employed population measures of mood and anxiety disorders to make inferences regarding the population prevalence and measurement properties of a combined measure. We used data from the 2012 Canadian Community Health Survey - Mental Health linked to health administrative databases in Ontario, Canada. Structured interview diagnoses were obtained from the survey, and health administrative diagnoses were identified using a standardised algorithm. These two prevalence estimates, in addition to data on the concordance between these measures and prior estimates of their psychometric properties, were used to inform our combined estimate. The marginal posterior densities of all parameters were estimated using Hamiltonian Monte Carlo (HMC), a Markov Chain Monte Carlo technique. Summaries of posterior distributions, including the means and 95% equally tailed posterior credible intervals, were used for interpretation of the results. The combined prevalence mean was 8.6%, with a credible interval of 6.8-10.6%. This combined estimate sits between Bayesian-derived prevalence estimates from administrative data-derived diagnoses (mean = 7.4%) and the survey-derived diagnoses (mean = 13.9%). The results of our sensitivity analysis suggest that varying the specificity of the survey-derived measure has an appreciable impact on the combined posterior prevalence estimate. Our combined posterior prevalence estimate remained stable when varying other prior information. We detected no problematic HMC behaviour, and our posterior predictive checks suggest that our model can reliably recreate our data. Accurate population-based estimates of disease are the cornerstone of health service planning and resource allocation. As a greater number of linked population data sources become available, so too does the opportunity for researchers to fully capitalise on the data. The true population prevalence of mood and anxiety disorders may reside between estimates obtained from survey data and health administrative data. We have demonstrated how the use of Bayesian approaches may provide a more informed and accurate estimate of mood and anxiety disorders in the population. This work provides a blueprint for future population-based estimates of disease using linked health data.

Identifiants

pubmed: 33413716
doi: 10.1017/S2045796020001080
pii: S2045796020001080
pmc: PMC8057492
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e4

Références

Int J Methods Psychiatr Res. 2006;15(4):167-80
pubmed: 17266013
Can Fam Physician. 2013 Apr;59(4):445
pubmed: 23585613
Popul Health Manag. 2012 Dec;15(6):372-80
pubmed: 22788998
Psychol Med. 2019 Nov;49(15):2637-2638
pubmed: 31566153
BMC Psychiatry. 2019 Jan 7;19(1):9
pubmed: 30616546
Int J Epidemiol. 2014 Apr;43(2):476-93
pubmed: 24648481
J Stat Softw. 2017;76:
pubmed: 36568334
Soc Psychiatry Psychiatr Epidemiol. 1998 Feb;33(2):80-8
pubmed: 9503991
Front Psychiatry. 2015 Jul 06;6:99
pubmed: 26217241
Issues Ment Health Nurs. 2005 Dec;26(10):979-99
pubmed: 16283995
Aust N Z J Psychiatry. 2009 Dec;43(12):1118-25
pubmed: 20001410
Am J Epidemiol. 1995 Feb 1;141(3):263-72
pubmed: 7840100
Can J Psychiatry. 2005 Nov;50(13):851-6
pubmed: 16483120
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
JAMA Psychiatry. 2015 Apr;72(4):334-41
pubmed: 25671328
Health Promot Chronic Dis Prev Can. 2017 Feb;37(2):54-62
pubmed: 28273041
CMAJ. 2006 Mar 14;174(6):787-91
pubmed: 16534085
Int J Methods Psychiatr Res. 2004;13(2):69-92
pubmed: 15297905
BMC Psychiatry. 2010 Dec 30;10:113
pubmed: 21192795
BJPsych Bull. 2015 Oct;39(5):242-7
pubmed: 26755969
Lancet Psychiatry. 2018 Feb;5(2):175-186
pubmed: 29033005
Psychol Med. 2003 Feb;33(2):357-62
pubmed: 12622315
BMC Public Health. 2011 Oct 31;11:837
pubmed: 22040030
Int J Methods Psychiatr Res. 2010 Jun;19 Suppl 1:4-22
pubmed: 20527002
Health Rep. 2014 Sep;25(9):3-9
pubmed: 25229895
Acta Psychiatr Scand. 2020 Apr;141(4):385-395
pubmed: 31883386

Auteurs

Jordan Edwards (J)

Department of Epidemiology & Biostatistics, The University of Western Ontario, London, Ontario, Canada.
Lawson Health Research Institute, London, Ontario, Canada.

A Demetri Pananos (AD)

Department of Epidemiology & Biostatistics, The University of Western Ontario, London, Ontario, Canada.

Amardeep Thind (A)

Department of Epidemiology & Biostatistics, The University of Western Ontario, London, Ontario, Canada.
Interfaculty Program in Public Health, The University of Western Ontario, London, Ontario, Canada.
Department of Family Medicine, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, Ontario, Canada.

Saverio Stranges (S)

Department of Epidemiology & Biostatistics, The University of Western Ontario, London, Ontario, Canada.
Department of Family Medicine, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, Ontario, Canada.
Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg.

Maria Chiu (M)

ICES, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

Kelly K Anderson (KK)

Department of Epidemiology & Biostatistics, The University of Western Ontario, London, Ontario, Canada.
Lawson Health Research Institute, London, Ontario, Canada.
ICES, Toronto, Ontario, Canada.
Department of Psychiatry, The University of Western Ontario, London, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH